Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Aug 28, 2023 8:00 am EDT

IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America

Aug 21, 2023 8:00 am EDT

IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium

Aug 14, 2023 8:00 am EDT

IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum

Aug 07, 2023 8:00 am EDT

IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023

Jul 24, 2023 8:00 am EDT

Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System

Jul 17, 2023 8:00 am EDT

IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales

Jun 13, 2023 8:00 am EDT

IceCure Medical to Review Recent Progress at Maxim Group's Virtual Healthcare Conference

May 31, 2023 8:00 am EDT

IceCure's ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country

May 22, 2023 8:00 am EDT

IceCure Medical Reports First Quarter 2023 Financial & Operational Results

May 15, 2023 8:25 am EDT

IceCure to Report First Quarter 2023 Financial & Operational Results on May 22, 2023

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2025 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023